Molecules, Vol. 28, Pages 6678: Pharmacoinformatics and Breed-Based De Novo Hybridization Studies to Develop New Neuraminidase Inhibitors as Potential Anti-Influenza Agents
Molecules, Vol. 28, Pages 6678: Pharmacoinformatics and Breed-Based De Novo Hybridization Studies to Develop New Neuraminidase Inhibitors as Potential Anti-Influenza Agents
Molecules doi: 10.3390/molecules28186678
Authors:
Bourougaa Lotfi
Ouassaf Mebarka
Bader Y. Alhatlani
Emad M. Abdallah
Sarkar M. A. Kawsar
Influenza represents a profoundly transmissible viral ailment primarily afflicting the respiratory system. Neuraminidase inhibitors constitute a class of antiviral therapeutics employed in the management of influenza. These inhibitors impede the liberation of the viral neuraminidase protein, thereby impeding viral dissemination from the infected cell to host cells. As such, neuraminidase has emerged as a pivotal target for mitigating influenza and its associated complications. Here, we apply a de novo hybridization approach based on a breed-centric methodology to elucidate novel neuraminidase inhibitors. The breed technique amalgamates established ligand frameworks with the shared target, neuraminidase, resulting in innovative inhibitor constructs. Molecular docking analysis revealed that the seven synthesized breed molecules (designated Breeds 1–7) formed more robust complexes with the neuraminidase receptor than conventional clinical neuraminidase inhibitors such as zanamivir, oseltamivir, and peramivir. Pharmacokinetic evaluations of the seven breed molecules (Breeds 1–7) demonstrated favorable bioavailability and optimal pe...
Source: Molecules - Category: Chemistry Authors: Bourougaa Lotfi Ouassaf Mebarka Bader Y. Alhatlani Emad M. Abdallah Sarkar M. A. Kawsar Tags: Article Source Type: research
More News: Chemistry | Influenza | Nanotechnology | Oseltamivir | Relenza | Respiratory Medicine | Study | Tamiflu | Zanamivir